Alimera Sciences To Release Third Quarter Fiscal Year 2015 Financial Results

ATLANTA, Oct. 29, 2015 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its third quarter fiscal year 2015 financial results after the market close on Thursday, November 5, 2015. An investor conference call will follow on the same day at 4:30 p.m. ET.

Dan Myers, President and Chief Executive Officer, and Rick Eiswirth, Chief Operating Officer and Chief Financial Officer, will host the conference call, during which they will discuss the results and provide commercial and other business updates.

To participate in the call, please dial (877) 369-6586 (U.S. and Canada) or (253) 237-1165 (International). A live webcast will be available on the Investor Relations section of the corporate website at www.alimerasciences.com.

A replay of the conference call will be available beginning on November 5, 2015 at 7:30 p.m. ET and ending on November 8, 2015 at 11:59 p.m. ET.  The replay can be accessed by dialing (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (International), Conference ID Number: 69995882. A replay of the webcast will also be available on the corporate website.

About Alimera Sciences, Inc.

Alimera Sciences, Inc., headquartered in Alpharetta, Georgia, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera's European operations are conducted from London by its subsidiary, Alimera Sciences Limited. For more information, please visit www.alimerasciences.com.

SOURCE Alimera Sciences, Inc.

Related Links

http://www.alimerasciences.com